Home

As COVID vaccine patent dispute drags on, Moderna forks over $400M to NIH

Moderna called the sum a "catch-up payment" for borrowing a molecular technique.

OPINION: NHI Bill must still clear many hurdles to ensure adequate medicine access

The Health Department’s recent response to submissions and its own recommendations on amendments to the National Health Insurance Bill sadly does not realise the gravity of the threat to the future of medicine selection and access. As the Bill currently stands, it will leave us at the mercy of advisory committees that bear no duty to be transparent in deciding which medicines people will be able to access under NHI, the authors argue.

OPINION: NHI Bill must still clear many hurdles to ensure adequate medicine access

The Health Department’s recent response to submissions and its own recommendations on amendments to the National Health Insurance Bill sadly does not realise the gravity of the threat to the future of medicine selection and access. As the Bill currently stands, it will leave us at the mercy of advisory committees that bear no duty to be transparent in deciding which medicines people will be able to access under NHI, the authors argue.

Passports and privilege: what does the future hold for global HIV conferences?

Visa issues prevented scores of scientists and activists from attending last year’s International AIDS Conference in Montréal after the Canadian government allegedly failed to fulfill commitments to fast-track applications. Now, the International AIDS Society (IAS) is changing how host cities are selected, but it may take radical transparency to help make more equitable access a reality.